Vimarsana
Biggest News Aggregation in the World

Tobym Maher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tobym Maher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tobym Maher Today - Breaking & Trending Today

Hedgehog Pathway Inhibitor Improves IPF - Vimarsana News

Hedgehog Pathway Inhibitor Improves IPF

Hedgehog pathway signaling inhibitor ENV-101 blocks signals that can lead to lung fibrosis and scarring and may lead to remodeling of early fibrosis.

Ziritaxestat fails to improve lung function in patients with idiopathic pulmonary fibrosis - Vimarsana News

Ziritaxestat fails to improve lung function in patients with idiopathic pulmonary fibrosis

WASHINGTON — In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation.“Unfortunately, ziritaxestat did not improve clinical outcomes compared with placebo in patients with IPF receiving standard of care,” Toby M.

Source: healio.com
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis - Vimarsana News

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

These 2 randomized clinical trials compare the efficacy and safety of 2 doses of the autotaxin inhibitor ziritaxestat vs placebo in patients with idiopathic pul